论文部分内容阅读
目的探讨无创呼吸机治疗慢性阻塞性肺疾病(COPD)合并呼吸衰竭患者的临床疗效。方法选取2013年1月至2014年12月通化市中心医院收治的86例COPD合并呼吸衰竭患者作为研究对象,按随机数字表法将其分为对照组和观察组,各43例。对照组患者给予常规对症治疗,观察组患者在对照组基础上采用BiPAP呼吸机进行治疗,比较两组患者的治疗有效率、住院时间、住院费用及治疗前后动脉血氧分压(PaO_2)、动脉血二氧化碳分压(PaCO_2)。结果观察组患者治疗的有效率明显高于对照组,住院时间明显短于对照组,住院费用明显低于对照组,差异均有统计学意义(均P<0.05);治疗后,观察组患者的PaO_2水平明显高于对照组,PaCO_2水平明显低于对照组,差异均有统计学意义(均P<0.05)。结论对COPD合并呼吸衰竭患者采用无创呼吸机进行治疗,可有效提高治疗效果,缩短住院时间,减少住院费用。
Objective To investigate the clinical efficacy of non-invasive ventilator in the treatment of patients with chronic obstructive pulmonary disease (COPD) and respiratory failure. Methods Totally 86 COPD patients with respiratory failure admitted to Tonghua Central Hospital from January 2013 to December 2014 were selected as study subjects and divided into control group and observation group according to random number table method, with 43 cases in each group. The patients in the control group were given conventional symptomatic treatment. The patients in the observation group were treated with BiPAP ventilator on the basis of the control group. The treatment efficiency, length of hospital stay, hospitalization cost and PaO_2 before and after treatment were compared between the two groups. Blood carbon dioxide partial pressure (PaCO_2). Results The effective rate of treatment in observation group was significantly higher than that of control group, the length of hospitalization was significantly shorter than that of control group, and the hospitalization cost was significantly lower than that of control group (all P <0.05); after treatment, the patients in observation group PaO_2 level was significantly higher than that of control group, PaCO_2 level was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusions The use of noninvasive ventilator for COPD patients with respiratory failure can effectively improve the treatment effect, shorten the hospital stay and reduce the cost of hospitalization.